WASHINGTON — Vijay Kumar, acting director of the office that reviews cell and gene therapies at the...
FDA’s top gene therapy regulator is leaving his role
WASHINGTON — Vijay Kumar, acting director of the office that reviews cell and gene therapies at the Food and Drug Administration, is stepping down from his...
Author: statnews.com
Read Original Article